XML 61 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
GENERAL (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Apr. 21, 2013
GENERAL [Abstract]      
Number of shares owned of Evogene investment 787,585    
Percentage of available for sale securities held by the company 2.09%    
Support received from investor under research and development funding arrangement $ 5,000    
Exchange rights, value of ordinary shares issuable less 50% of cash consideration paid     13,000
Minimum price per share     $ 3.00
Maximum price per share     $ 12.00
Number of shares called by warrant     500,000
Exercise price of warrant issued     7.50
Net proceeds from At-the-Market program 7,324 3,663  
Gross value of all shares issued, sold and unsold under At-the-Market program $ 40,000    
Common shares issued during period, under At-the-Market program 1,338,285